Prognostic value of systemic inflammatory index (SII) in neuroendocrine tumors (NETs) treated with peptide receptor radionuclide therapy (PRRT)

被引：0
作者：
Teran Brage, E. [1 ]
Reguera Puertas, P. [1 ]
Campana-Diaz, E. [2 ]
Navarro Martin, M. [1 ]
Garcia Talavera, P. [2 ]
Rama Alonso, S. [2 ]
Lopez Gutierrez, A. [1 ]
Roldan Ruiz, J. [1 ]
Garijo Martinez, M. D. C. [1 ]
Morchon Araujo, D. [1 ]
Posado-Dominguez, L. [1 ]
Redondo Gonzalez, J. C. [1 ]
Diaz Sanchez, P. [1 ]
Pablo Martin, E. [1 ]
Felix, L. C. [1 ]
Lozano Mejorada, R. [1 ]
Fonseca Sanchez, E. [1 ]
机构：
[1] Univ Hosp Salamanca, Med Oncol Dept, Salamanca, Spain
[2] Univ Hosp Salamanca, Nucl Med Dept, Salamanca, Spain
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.1222
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1163P
引用
收藏
页码：S758 / S759
页数：2
相关论文
共 50 条
  • [1] Systemic inflammatory index (SII) in neuroendocrine tumors (NETs) treated with peptide receptor radionuclide therapy (PRRT)
    Teran Brage, E.
    Campana-Diaz, E.
    Navarro Martin, M.
    Garcia-Talavera, P.
    Lopez Gutierrez, A.
    Reguera Puertas, P.
    Rama-Alonso, S.
    Roldan Ruiz, J.
    Posado Dominguez, L.
    Pablo Martin, E.
    Lozano Mejorada, R.
    Fonseca Sanchez, E.
    ANNALS OF ONCOLOGY, 2024, 35 : S95 - S95
  • [2] The role of systemic inflammatory factors in gastroenteropancreatic neuroendocrine tumors (GEP-NETs) treated with peptide receptor radionuclide therapy (PRRT).
    Abou Jokh Casas, Estephany
    Lago, Nieves Martinez
    Cabezas Agricola, Jose Manuel
    Herranz, Urbano Anido
    Baron, Francisco
    Calvo, Ovidio Fernandez
    Varela, Maria Quindos
    Ferreiro, Silvia Varela
    Maseda, Alberto Carral
    De Matias Leralta, Jose Maria
    Seoane, Zulema Nogareda
    Castineira, Antia Cousillas
    Martinez de LLano, Sofia Rodriguez
    Mato Mato, Jose Antonio
    Catalina, Pablo Fernandez
    Fonseca, Omar Rodriguez
    Garcia, Gloria Muniz
    Bernardez, Beatriz
    Cameselle Teijeiro, Jose Manuel
    Nunez, Virginia Pubul
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [3] Role of systemic inflammatory factors in gastroenteropancreatic neuroendocrine tumors (GEP-NETs) treated with peptide receptor radionuclide therapy (PRRT): From biology to theragnosis
    Casas, E. Abou-Jokh
    Martinez-Lagob, N.
    Araujo, M. C. Mallon
    Agricolac, J. M. Cabezas
    Seoaned, Z. Nogareda
    Castineirae, A. Cousillas
    Morellf, A. Ruibal
    Nuneza, V. Pubul
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2023, 42 (03): : 156 - 162
  • [4] Toxicity identification and evaluation of peptide receptor radionuclide therapy (PRRT) for neuroendocrine tumors (NETs)
    Duan, Heying
    Girod, Bradley
    Ninatti, Gaia
    Ferri, Valentina
    Kunz, Pamela
    Fisher, George
    Moradi, Farshad
    Davidzon, Guido
    Franc, Benjamin
    Iagaru, Andrei
    Aparici, Carina Mari
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [5] Peptide Receptor Radionuclide Therapy (PRRT) for Metastatic Neuroendocrine Tumors (NETs): A United States Experience
    Katona, Bryson
    Riff, Brian
    Soulen, Michael
    Pryma, Daniel
    Bennett, Bonita
    Wild, Damian
    Nicolas, Guillaume
    Teitelbaum, Ursina
    Metz, David
    PANCREAS, 2017, 46 (03) : 439 - 439
  • [6] Outcomes of peptide receptor radionuclide therapy (PRRT) in metastatic grade 3 neuroendocrine tumors (NETs).
    Lung, Mei Sim
    Hofman, Michael
    Kong, Grace
    Thang, Sue-Ping
    Michael, Michael
    Hicks, Rodney J.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [7] Peptide Receptor Radionuclide Therapy (PRRT) for Metastatic Neuroendocrine Tumors (NETs) in a United States (US) Population
    Katona, Bryson W.
    Riff, Brian P.
    Soulen, Michael C.
    Pryma, Daniel A.
    Bennett, Bonita J.
    Wild, Damian
    Nicolas, Guillaume
    Teitelbaum, Ursina R.
    Metz, David C.
    GASTROENTEROLOGY, 2016, 150 (04) : S208 - S209
  • [8] Peptide receptor radionuclide therapy (PRRT) in metastatic neuroendocrine tumors of unknown primary (CUP-NETs)
    Baum, Richard P.
    Wang, Peipei
    Jakobsson, Vivianne
    Zhao, Tianzhi
    Schuchardt, Christiane
    Khong, Pek-Lan
    Zhang, Jingjing
    THERANOSTICS, 2024, 14 (01): : 133 - 142
  • [9] Peptide receptor radionuclide therapy (PRRT) of neuroendocrine tumors with somatostatin analogues
    Bodei, L.
    Pepe, G.
    Paganelli, G.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2010, 14 (04) : 347 - 351
  • [10] The value of dosimetry in Peptide Receptor Radionuclide Therapy (PRRT) for neuroendocrine tumors: literature and practical aspects
    Di Dia, Amalia
    Ferrari, Mahila E.
    Travaini, Laura Lavinia
    Grappeja, Lorenza
    Guglielmo, Priscilla
    Barone, Antonio
    Mei, Riccardo
    Papi, Stefano
    Ceci, Francesco
    Grana, Chiara Maria
    CLINICAL AND TRANSLATIONAL IMAGING, 2025, : 121 - 129
12345